Credit: NIAID-RML, CC BY 2.0 (https://creativecommons.org/licenses/by/2.0/deed.en)
The BioScience Talks podcast features discussions of topical issues related to the biological sciences.
Public health officials have argued that thorough and accurate testing for SARS-CoV-2 is essential for gaining a foothold in the fight against the deadly COVID-19 pandemic. To date, however, a lack of reliable testing in the United States has hampered efforts to achieve a thorough understanding of the disease’s abundance and spread.
In this episode of BioScience Talks, we are joined by Dr. Crystal Icenhour, CEO of Aperiomics, and Dr. Robbie Barbero, Chief Business Officer of Ceres Nanosciences. Both companies have recently ramped up efforts to improve the prospects of broad-scale testing for the novel pathogen in human patients.
Aperiomics, whose core technology uses deep shotgun metagenomic sequencing to test for tens of thousands of bacteria, virus, fungus, and parasite at once, has launched a SARS-CoV-2-specific test, with the aims of increasing test availability and delivering crucially important public health data. Ceres Nanosciences’s flagship Nanotrap particle technology enables the capture, concentration, and preservation of low abundance analytes from complex biological samples. The technology is presently being tested with the SARS-CoV-2 and is expected to help in improving the accuracy of existing testing protocols.
To hear the whole discussion, visit this link for this latest episode of the BioScience Talks podcast.
###
BioScience, published monthly by Oxford Journals, is the journal of the American Institute of Biological Sciences (AIBS). BioScience is a forum for integrating the life sciences that publishes commentary and peer-reviewed articles. The journal has been published since 1964. AIBS is an organization for professional scientific societies and organizations, and individuals, involved with biology. AIBS provides decision-makers with high-quality, vetted information for the advancement of biology and society. Follow BioScience on Twitter @BioScienceAIBS.
Oxford Journals is a division of Oxford University Press. Oxford Journals publishes well over 300 academic and research journals covering a broad range of subject areas, two-thirds of which are published in collaboration with learned societies and other international organizations. The division been publishing journals for more than a century, and as part of the world’s oldest and largest university press, has more than 500 years of publishing expertise behind it. Follow Oxford Journals on Twitter @OxfordJournals
Media Contact
James M Verdier
[email protected]
